tiprankstipranks
Eli Lilly & Co (LLY)
NYSE:LLY
US Market

Eli Lilly & Co (LLY) Income Statement

Compare
15,036 Followers

Eli Lilly & Co Income Statement

Last quarter (Q4 2024), Eli Lilly & Co's total revenue was $13.53B, an increase of 44.68% from the same quarter last year. In Q4, Eli Lilly & Co's net income was $4.41B. See Eli Lilly & Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 45.04B$ 34.12B$ 28.54B$ 28.32B$ 24.54B
Gross Profit
$ 36.62B$ 27.04B$ 21.91B$ 21.01B$ 19.06B
Operating Expenses
$ 23.73B$ 16.72B$ 13.63B$ 13.46B$ 12.21B
Depreciation and Amortization
$ 1.71B$ 1.53B$ 1.52B$ 1.55B$ 1.32B
EBITDA
$ 18.75B$ 8.57B$ 8.66B$ 8.04B$ 8.91B
Operating Income
$ 12.90B$ 10.33B$ 7.13B$ 6.36B$ 6.06B
Other Income/Expenses
$ -218.60M$ -3.77B$ -1.85B$ -201.60M$ 19.10M
Pretax Income
$ 12.68B$ 6.55B$ 6.81B$ 6.16B$ 7.23B
Net Income
$ 10.59B$ 5.24B$ 6.24B$ 5.58B$ 6.19B
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 11.71$ 5.83$ 6.93$ 6.15$ 6.82
Diluted EPS
$ 11.71$ 5.80$ 6.90$ 6.12$ 6.79
Weighted Average Shares Outstanding
904.36M 899.38M 901.74M 906.96M 907.63M
Weighted Average Shares Outstanding (Diluted)
904.06M 903.28M 904.62M 911.68M 912.50M
Currency in USD

Eli Lilly & Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis